Skip to main content
Clinical Trials/JPRN-jRCTs032220010
JPRN-jRCTs032220010
Recruiting
Phase 1

A clinical trial to evaluate the usefulness of intraoperative intestinal blood f low assessment using an endoscope for the gastrointestinal tract

Matsubara Hisahiro0 sites40 target enrollmentApril 8, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Colorectal Cancer
Sponsor
Matsubara Hisahiro
Enrollment
40
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 8, 2022
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Matsubara Hisahiro

Eligibility Criteria

Inclusion Criteria

  • Patients who meet all of the following conditions a re eligible.
  • (1\) Patients undergoing colorectal cancer surgery with gastrointestinal anastomosis
  • (2\) Patients must be 20 years of age or older at the time of consent.
  • (3\) Patients whose major organs are functioning a dequately and who are judged by the investigator to be able to undergo surgery safely.
  • (4\) Patients who have received sufficient explanati ons about participation in this study and have give n written consent of their own free will with suffici ent understanding.

Exclusion Criteria

  • Patients who meet any of the following conditions are not eligible for the study.
  • (1\) Patients with a history of allergy to ICG or iodin e hypersensitivity
  • 2\) Patients with preoperative intestinal obstruction
  • 3\) Patients who have received preoperative treatm ent (e.g., anticancer drug therapy, radiotherapy, c olorectal stent)
  • 4\) Patients who are scheduled to have two or mor e anastomoses
  • 5\) Patients with infection in the abdominal cavity 6\) Patients with serious comorbidities (cardiac dis ease, pulmonary disease, autoimmune disease, ble eding tendency, poorly controlled hypertension or diabetes, etc.)
  • 7\) Pregnant patients
  • 8\) Patients who are considered inappropriate for participation in the study by the principal investig ator or sub\-investigator.

Outcomes

Primary Outcomes

Not specified

Similar Trials